OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals February 4, 2025
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development February 4, 2025
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology January 28, 2025
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology January 21, 2025
Simnova and Orna Expand Strategic Partnership to Include BCMA-Targeted RNA Therapeutics January 21, 2025
ArsenalBio and BMS Achieve Milestone for AB-4000 Series to Advance Next-Gen T Cell Therapies for Solid Tumors January 21, 2025
A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Precision Cell Therapies Using Proprietary Tmod Technology Platform January 21, 2025
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma January 21, 2025
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs January 21, 2025
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology January 15, 2025
AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma January 15, 2025
Avenzo Therapeutics and DualityBio Announce Exclusive Global License for EGFR/HER3 ADC January 15, 2025
BrainChild Bio, Inc. to clinically advance BCB-276, an autologous B7-H3 targeting CAR T-cell therapy for incurable pediatric brain tumors January 15, 2025
Biocytogen and Acepodia to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors January 15, 2025
Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform January 15, 2025
Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology January 15, 2025
NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products January 15, 2025
Asher Bio Announces Clinical Trial Collaboration & Supply Agreement on Etakafusp Alfa (AB248) in Combination with Bispecific T-cell Engager in SCLC Patients January 15, 2025
Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale January 15, 2025
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 ADC January 7, 2025
